SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-19-118086
Filing Date
2019-04-25
Accepted
2019-04-25 08:03:05
Documents
10
Effectiveness Date
2019-04-25

Document Format Files

Seq Description Document Type Size
1 DEFA14A d719156ddefa14a.htm DEFA14A 32551
2 GRAPHIC g71915639.jpg GRAPHIC 18132
3 GRAPHIC g719156391.jpg GRAPHIC 9870
4 GRAPHIC g719156394.jpg GRAPHIC 2370
5 GRAPHIC g719156396.jpg GRAPHIC 9219
6 GRAPHIC g719156g01k03.jpg GRAPHIC 1242
7 GRAPHIC g719156g12m70.jpg GRAPHIC 1932
8 GRAPHIC g719156g45w32.jpg GRAPHIC 1828
9 GRAPHIC g719156g68m19.jpg GRAPHIC 2814
10 GRAPHIC g719156g97k74.jpg GRAPHIC 2115
  Complete submission text file 0001193125-19-118086.txt   103131
Mailing Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37813 | Film No.: 19765431
SIC: 2834 Pharmaceutical Preparations